| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 1.925 | 10.788 | 9.749 | 9.420 | 8.447 | 7.331 |
| Total Income - EUR | - | - | - | - | 1.925 | 10.788 | 9.749 | 9.420 | 8.452 | 7.331 |
| Total Expenses - EUR | - | - | - | - | 445 | 1.703 | 7.404 | 3.024 | 6.683 | 6.377 |
| Gross Profit/Loss - EUR | - | - | - | - | 1.480 | 9.085 | 2.345 | 6.396 | 1.769 | 955 |
| Net Profit/Loss - EUR | - | - | - | - | 1.422 | 8.769 | 2.052 | 6.114 | 1.529 | 820 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Lollypopmed Bod S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 1.402 | 775 | 22.992 | 22.718 | 19.010 | 15.193 |
| Current Assets | - | - | - | - | 1.908 | 9.212 | 3.462 | 7.377 | 9.861 | 6.278 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 635 | 4.947 | 1.204 | 1.812 | 2.339 | 335 |
| Cash | - | - | - | - | 1.273 | 4.265 | 2.258 | 5.565 | 7.521 | 5.944 |
| Shareholders Funds | - | - | - | - | 1.464 | 8.819 | 5.674 | 11.806 | 13.299 | 14.044 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 1.846 | 1.169 | 20.780 | 18.290 | 15.572 | 7.427 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Lollypopmed Bod S.r.l.